FDA approves Takeda's orexin drug for narcolepsy
One of the most closely watched commercial drug races is now off and running, after Takeda snagged FDA approval of its orexin agonist to treat narcolepsy type 1. The FDA
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.